First Venture Technologies Corp.
TSX VENTURE : FEB

First Venture Technologies Corp.

August 15, 2007 13:44 ET

First Venture Clarifies eResearch News Release

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 15, 2007) - First Venture Technologies Corp. (TSX VENTURE:FEB) reports that Independent Equity Research Corp., operating as eResearch, has issued a news release dated August 14, 2007, announcing their publication of an Update Report on First Venture Technologies Corp. and their target price on the Company's stock. First Venture Technologies has not engaged in the determination of this or any other target price, and due to securities laws are unable to endorse any target price.

ON BEHALF OF THE BOARD

Geoff Lee, Chief Financial Officer

ABOUT FIRST VENTURE TECHNOLOGIES

First Venture is a biotechnology company that develops and commercializes advanced yeast products.

The company is currently commercializing a platform yeast technology that substantially reduces the formation of a known carcinogen, ethyl carbamate (or urethane) from food products and alcoholic beverages. The company has licensed the exclusive worldwide rights to the technology from The University of British Columbia (UBC).

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information